Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.02.24
Overseas Regulatory Announcement
2023.02.24
Overseas Regulatory Announcement
2023.02.24
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司关于“20ag真人平台官方”回售结果暨摘牌公告
2023.02.24
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司2020年面向合格投资者公开发行公司债券（疫情...
2023.01.31
POSITIVE PROFIT ALERT ANNOUNCEMENT ON THE ESTIMATED INCREASE IN PROFIT FOR THE A...
2023.01.31
ag真人平台官方：2022年度业绩预告
2023.01.10
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司关于“20ag真人平台官方”票面利率调整暨投资者回售实施...
2023.01.10
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司关于“20ag真人平台官方”票面利率调整暨投资者回售实施...
2023.01.10
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司关于“20ag真人平台官方”票面利率调整暨投资者回售实施...
2022.12.28
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司关于拟下调“20ag真人平台官方”公司债券票面利率的提示...
第一页
上一页
23
24
25
26
27
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
